Sus Clinicals solves major problems in qualifying new cancer drugs, devices, diagnostics and therapies. Using a proprietary model of testing on genetically-modified pigs pioneered at the University of Illinois, Sus Clinicals leverages the inherent advantages of a patent-pending large animal testing methodology combined with novel clinical approaches to reduce false positives, model the interactions of multiple diseases, and accelerate progress toward human trials for the most promising therapies.
Company Details
- Employees
- 14
- Founded
- 2020
- Address
- Cincinnati, Ohio, Us
- in****@****als.com
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- susclinicals.com
- Keywords
- Cincinnati.
- HQ
- Cincinnati, Ohio
Sus Clinicals, Inc. Questions
Sus Clinicals, Inc.'s website is susclinicals.com
Sus Clinicals, Inc.'s LinkedIn profile is https://www.linkedin.com/company/susclinicals
Sus Clinicals, Inc. has
14 employees.
View email and phone details for 14
employees at Sus Clinicals, Inc..
Sus Clinicals, Inc.'s industry is
Research Services
Sus Clinicals, Inc.'s top competitors are
Swarmdynamics.ai,
Oncoscope-Ai,
Triomics,
Amrok,
Tempus Ai,
Traq.ai,
Neucore Bio,
Courselynx,
Forte Research Systems, Inc.,
Medlior Health Outcomes Research Ltd..
Sus Clinicals, Inc.'s support email address is info@susclinicals.com
Sus Clinicals, Inc.'s categories are Research Services
Sus Clinicals, Inc.'s founding year is 2020
